Gabapentin
Product Images NDC 54868-5219

8 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 54868-5219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 600 mg Package Label (600mg Package Label)

Image Of 600 mg Package Label (600mg Package Label)
Gabapentin tablets 600 mg label from Physicians Total Care, Inc. The label includes the NDC 54868-5219-6, package quantity of 30 tablets, caution about federal law prohibiting dispensing without prescription, and storage instructions. It also includes lot number, expiration date, and barcode information.*
FDA Label Image

Image Of 800 mg Package Label (800mg Package Label)

Image Of 800 mg Package Label (800mg Package Label)
Gabapentin 800 mg tablets packaging label from Physicians Total Care, Inc. The label indicates a quantity of 60 tablets, includes dosage strength and Federal caution against dispensing without prescription. It provides usual dosage recommendations, storage instructions, and warnings including keeping out of reach of children. Lot number and expiration date areas are also visible.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A line chart comparing the mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period, while the y-axis represents mean pain score from 0 to 10. Gabapentin shows a consistent decrease in pain score over time compared to placebo, with statistically significant differences noted (p < 0.01).*
FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
A line graph comparing mean pain scores over 7 weeks for placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph shows a 3-week dose titration period followed by a 4-week fixed dose period, with lower mean pain scores observed for both Gabapentin doses compared to placebo throughout the study.*
FDA Label Image

Image Of Figure 3 (Figure 3)

Image Of Figure 3 (Figure 3)
A bar graph comparing the percentage of responders at endpoint across two studies. It shows results for placebo (PBO) and Gabapentin (GBP) dosages of 1800 mg, 2400 mg, and 3600 mg. The graph includes significance markers for the differences between groups in response rates.*
FDA Label Image

Image Of Figure 4 (Figure 4)

Image Of Figure 4 (Figure 4)
A scatter plot chart showing the percentage difference on the y-axis versus daily dose in mg on the x-axis (600, 900, 1200, 1800 mg) for Gabapentin. The chart compares results from three studies labeled as Study a, Study b, and Study c, depicting data points with differences ranging approximately from 7% to 18%.*
FDA Label Image
Image Of Glenmark Logo (Glenmark Logo)
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of gabapentin, showing a cyclohexane ring with side chains including an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.